Andreas Marchler

The ZETA Group, with 1700+ highly qualified employees and 31 subsidiaries worldwide, specializes in planning, automation, digitalization and qualification of customized biopharmaceutical facilities for aseptic process solutions. ZETA acts as an end-to-end solution provider, combining plant engineering with HVAC and cleanroom design. Biopharmaceutical active ingredients, such as anti-cancer drugs, insulin, vaccines and infusions are produced in these highly complex, "tailor-made" facilities. ZETA supports its customers along the entire drug development and manufacturing pathway with sophisticated solutions from laboratory to industrial production scale. Through its Smart Engineering Services, ZETA creates digital twins of process plants and has thus established itself as a market leader for digital solutions in the pharmaceutical and biotech industry. ZETA is also actively taking steps towards a more sustainable future for the industry as a whole: through ZETA's decarbonization strategies, emissions are specifically reduced during the biopharmaceutical manufacturing process.